Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy

This study has been completed.

Study NCT00343720 Information provided by Millennium Pharmaceuticals, Inc.

First Received: June 22, 2006 Last Updated: March 11, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	October 2007 (Final data collection date for primary outcome measure)